Products for Research Use Only
RegisterLogin

Umbralisib (Standard)

CAT: 0804-HY-12279R-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-12279R-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Umbralisib (Standard) is the analytical standard of Umbralisib. This product is intended for research and analytical applications. Umbralisib (TGR-1202) is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50 of 22.2 nM and 6.0 μM, respectively. Umbralisib exhibits unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib can be used for haematological malignancies reseach[1][2][3][4].
CAS Number
1532533-67-7
UNSPSC
12352100
Target
Casein Kinase; PI3K; Reference Standards
Related Pathways
Cell Cycle/DNA Damage; Others; PI3K/Akt/mTOR; Stem Cell/Wnt
Field of Research
Cancer
Smiles
O=C1C(C2=CC=CC(F)=C2)=C([C@@H](N3N=C(C4=CC=C(OC(C)C)C(F)=C4)C5=C(N)N=CN=C53)C)OC6=CC=C(F)C=C16
Molecular Formula
C31H24F3N5O3
Molecular Weight
571.55
References & Citations
[1]Swaroop Vakkalankaa, et al. Inhibition of PI3Kδ kinase by a selective, small molecule inhibitor suppresses B-cell proliferation and leukemic cell growth.|[2]Deng C, et al. Silencing c-Myc translation as a therapeutic strategy through targeting PI3Kδ and CK1ε in hematological malignancies. Blood. 2017 Jan 5;129 (1) :88-99|[3]Maharaj K, et al. The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells. Blood Adv. 2020 Jul 14;4 (13) :3072-3084.|[4]Burris HA 3rd, et al. Umbralisib, a novel PI3Kδ and casein kinase-1ε inhibitor, in relapsed or refractory chronic lymphocytic leukaemia and lymphoma: an open-label, phase 1, dose-escalation, first-in-human study. Lancet Oncol. 2018 Apr;19 (4) :486-496.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards

Related Products

CatalogName
HY-12279CRUmbralisib (hydrochloride) (Standard)
HY-12279-01Umbralisib
HY-12279BUmbralisib (sulfate)
HY-12279AUmbralisib (tosylate)
HY-12279C-01Umbralisib (hydrochloride)
HY-12279F-01Umbralisib R-enantiomer
HY-P2274RArgifin (Standard)
HY-N9362REmodinanthrone (Standard)
HY-N7948RIsomaltotetraose (Standard)
HY-N7640RDeoxylimonin (Standard)

Alternative Products

CatalogName
205938Umbralisib
T17066Umbralisib hydrochloride
MBS5814888Umbralisib sulfate
MBS5814848Umbralisib tosylate
MBS5754038Umbralisib R-enantiomer
C13255-01Umbralisib (TGR-1202)
MBS3841541-01TGR-1202 (Umbralisib)

Popular Products